Abstract
In 2007, the combined US, European, and Japanese markets for hysterectomy
alternative devices were valued at nearly $450 million.
This market consisted of global endometrial ablation (GEA) devices,
hysteroscopes, endometrial resection devices, and uterine artery embolization
(UAE) products.
View Cart
